These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15639192)

  • 1. Molecular and clinical description of the first US patients with congenital disorder of glycosylation Ig.
    Eklund EA; Newell JW; Sun L; Seo NS; Alper G; Willert J; Freeze HH
    Mol Genet Metab; 2005 Jan; 84(1):25-31. PubMed ID: 15639192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik.
    Grubenmann CE; Frank CG; Hülsmeier AJ; Schollen E; Matthijs G; Mayatepek E; Berger EG; Aebi M; Hennet T
    Hum Mol Genet; 2004 Mar; 13(5):535-42. PubMed ID: 14709599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N-glycan synthesis.
    Grünewald S; Imbach T; Huijben K; Rubio-Gozalbo ME; Verrips A; de Klerk JB; Stroink H; de Rijk-van Andel JF; Van Hove JL; Wendel U; Matthijs G; Hennet T; Jaeken J; Wevers RA
    Ann Neurol; 2000 Jun; 47(6):776-81. PubMed ID: 10852543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbohydrate deficient glycoprotein syndrome type IV: deficiency of dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase.
    Körner C; Knauer R; Stephani U; Marquardt T; Lehle L; von Figura K
    EMBO J; 1999 Dec; 18(23):6816-22. PubMed ID: 10581255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a frequent variant in ALG6, the cause of Congenital Disorder of Glycosylation-Ic.
    Westphal V; Xiao M; Kwok PY; Freeze HH
    Hum Mutat; 2003 Nov; 22(5):420-1. PubMed ID: 14517965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of multiple mutations in the hALG6 gene in a patient with congenital disorder of glycosylation Ic.
    Westphal V; Schottstädt C; Marquardt T; Freeze HH
    Mol Genet Metab; 2000 Jul; 70(3):219-23. PubMed ID: 10924277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblasts.
    Eklund EA; Merbouh N; Ichikawa M; Nishikawa A; Clima JM; Dorman JA; Norberg T; Freeze HH
    Glycobiology; 2005 Nov; 15(11):1084-93. PubMed ID: 16079417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy.
    Barone R; Aiello C; Race V; Morava E; Foulquier F; Riemersma M; Passarelli C; Concolino D; Carella M; Santorelli F; Vleugels W; Mercuri E; Garozzo D; Sturiale L; Messina S; Jaeken J; Fiumara A; Wevers RA; Bertini E; Matthijs G; Lefeber DJ
    Ann Neurol; 2012 Oct; 72(4):550-8. PubMed ID: 23109149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie.
    Imbach T; Schenk B; Schollen E; Burda P; Stutz A; Grunewald S; Bailie NM; King MD; Jaeken J; Matthijs G; Berger EG; Aebi M; Hennet T
    J Clin Invest; 2000 Jan; 105(2):233-9. PubMed ID: 10642602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and molecular features of congenital disorder of glycosylation in patients with type 1 sialotransferrin pattern and diverse ethnic origins.
    Enns GM; Steiner RD; Buist N; Cowan C; Leppig KA; McCracken MF; Westphal V; Freeze HH; O'brien JF; Jaeken J; Matthijs G; Behera S; Hudgins L
    J Pediatr; 2002 Nov; 141(5):695-700. PubMed ID: 12410200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term evolution of eight Spanish patients with CDG type Ia: typical and atypical manifestations.
    Pérez-Dueñas B; García-Cazorla A; Pineda M; Poo P; Campistol J; Cusí V; Schollen E; Matthijs G; Grunewald S; Briones P; Pérez-Cerdá C; Artuch R; Vilaseca MA
    Eur J Paediatr Neurol; 2009 Sep; 13(5):444-51. PubMed ID: 18948042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A severe human metabolic disease caused by deficiency of the endoplasmatic mannosyltransferase hALG11 leads to congenital disorder of glycosylation-Ip.
    Rind N; Schmeiser V; Thiel C; Absmanner B; Lübbehusen J; Hocks J; Apeshiotis N; Wilichowski E; Lehle L; Körner C
    Hum Mol Genet; 2010 Apr; 19(8):1413-24. PubMed ID: 20080937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALG1-CDG: a new case with early fatal outcome.
    Rohlfing AK; Rust S; Reunert J; Tirre M; Du Chesne I; Wemhoff S; Meinhardt F; Hartmann H; Das AM; Marquardt T
    Gene; 2014 Jan; 534(2):345-51. PubMed ID: 24157261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib).
    Schollen E; Dorland L; de Koning TJ; Van Diggelen OP; Huijmans JG; Marquardt T; Babovic-Vuksanovic D; Patterson M; Imtiaz F; Winchester B; Adamowicz M; Pronicka E; Freeze H; Matthijs G
    Hum Mutat; 2000 Sep; 16(3):247-52. PubMed ID: 10980531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type Ib: long-term outcome and effects of mannose supplementation.
    Westphal V; Kjaergaard S; Davis JA; Peterson SM; Skovby F; Freeze HH
    Mol Genet Metab; 2001 May; 73(1):77-85. PubMed ID: 11350186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital disorder of glycosylation Ic due to a de novo deletion and an hALG-6 mutation.
    Eklund EA; Sun L; Yang SP; Pasion RM; Thorland EC; Freeze HH
    Biochem Biophys Res Commun; 2006 Jan; 339(3):755-60. PubMed ID: 16321363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of dolichyl-P-Man:Man7GlcNAc2-PP-dolichyl mannosyltransferase causes congenital disorder of glycosylation type Ig.
    Thiel C; Schwarz M; Hasilik M; Grieben U; Hanefeld F; Lehle L; von Figura K; Körner C
    Biochem J; 2002 Oct; 367(Pt 1):195-201. PubMed ID: 12093361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of two unusual truncating PMM2 mutations in two CDG-Ia patients.
    Schollen E; Keldermans L; Foulquier F; Briones P; Chabas A; Sánchez-Valverde F; Adamowicz M; Pronicka E; Wevers R; Matthijs G
    Mol Genet Metab; 2007 Apr; 90(4):408-13. PubMed ID: 17307006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new intronic mutation in the DPM1 gene is associated with a milder form of CDG Ie in two French siblings.
    Dancourt J; Vuillaumier-Barrot S; de Baulny HO; Sfaello I; Barnier A; le Bizec C; Dupre T; Durand G; Seta N; Moore SE
    Pediatr Res; 2006 Jun; 59(6):835-9. PubMed ID: 16641202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital disorder of glycosylation type Ia: a clinicopathological report of a newborn infant with cerebellar pathology.
    Aronica E; van Kempen AA; van der Heide M; Poll-The BT; van Slooten HJ; Troost D; Rozemuller-Kwakkel JM
    Acta Neuropathol; 2005 Apr; 109(4):433-42. PubMed ID: 15714316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.